About Monocacy Therapeutics
Monocacy Therapeutics is a private company based in Monrovia, Maryland, incorporated in 2025 in Delaware. It has reported $414,499 raised in five offerings on Form D since May 2026.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Oct 7, 2026 | $25,000fully sold | 1 | $25,000 | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| Sep 3, 2026 | Sep 21, 2026 | $49fully sold | 1 | $49 | EquityRule 506(b) | Form D ↗ |
| Jul 23, 2026 | Aug 28, 2026 | $150,000fully sold | 1 | $150K | EquityRule 506(b) | Form D ↗ |
| Not yet | Aug 28, 2026 | $125,000fully sold | 5 | $25,000 | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| May 5, 2026 | May 27, 2026amended Aug 28, 2026 | $114,450target not set | 2 | $57,225 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, five offerings | $414,499 | |||||
The filing for the offering first filed Aug 28, 2026 reports amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Monocacy Therapeutics's Form D filed Oct 7, 2026.
SV
Suman Vodnala
Executive officer
SP
Shashank Patel
President and director